Union Budget 2024: `Advanced treatments are still expensive`
The Union Budget 2024 was announced earlier today and saw quite a few advancements that will shape the future of India. While experts dissect the many different areas that will see a significant impact, its impact on healthcare is promising, especially for cancer treatment, believe healthcare experts.
With a boost to healthcare, India`s Finance Minister Nirmala Sitharaman, announced that three cancer medicines Trastuzumab deruxtecan, Osimertinib and Durvalumab have been fully exempted from custom duty for cancer patients. Further, there will also be changes in basic customs duty on X-Ray tubes and flat panel detectors for domestic X-ray machines`s production.
With such important changes, mid-day.com spoke to India`s healthcare experts to get their reactions.
Reny Varghese, CAO, Zynova...









